Maker's videoMicroPort · 24 April 2024
Expanding access to medical solutions | MicroPort®
Against the record
Toumai, from MicroPort MedBot (MicroPort group), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 22 July 2026: MicroPort MedBot, Toumai's maker, said it expected its first-ever half-year profit, of about 28 to 40 million yuan.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
2023 saw #MicroPort expand access to medical solutions by securing 15 FDA approvals, 10 CE certifications, and 30 NMPA Green Path product launches. Learn more about us: www.microport.com. Follow us on LinkedIn: www.linkedin.com/company/microport/. Follow us on Twitter: www.twitter.com/MicroPort.
Written by MicroPort on YouTube.
More videos of Toumai
Cutting-edge robotic surgery solutions | MicroPort® MedBot™
Cutting-edge robotic surgery solutions | MicroPort® MedBot™
Medical technologies that benefit a patient every 5 seconds | MicroPort®
Medical technologies that benefit a patient every 5 seconds | MicroPort®
Fostering medical innovation that improves patient outcomes | MicroPort®
Fostering medical innovation that improves patient outcomes | MicroPort®